European Journal of Chemistry 2019, 10(4), 350-357 | doi: https://doi.org/10.5155/eurjchem.10.4.350-357.1899 | Get rights and content






  OPEN ACCESS | PEER-REVIEWED | RESEARCH ARTICLE | DOWNLOAD PDF | VIEW FULL-TEXT PDF | TOTAL VIEWS

Pure component contribution (PCCA) and synergy interval partial least squares (siPLS) algorithms for efficient resolution and quantification of overlapped signals; an application to novel antiviral tablets of daclatasvir, sofosbuvir and ribavirin


Maha Mahmoud Abou El-Alamin (1) orcid , Maha Abd Elrahman Sultan (2) orcid , Maha Hegazy (3) orcid , Alastair William Wark (4) orcid , Marwa Mohamed Azab (5,*) orcid

(1) Analytical Chemistry Department, Faculty of Pharmacy, Helwan University, Ain Helwan, Cairo, 11795, Egypt
(2) Analytical Chemistry Department, Faculty of Pharmacy, Helwan University, Ain Helwan, Cairo, 11795, Egypt
(3) Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, Cairo, 11562, Egypt
(4) Centre for Molecular Nanometrology, Department of Pure and Applied Chemistry, Technology and Innovation Centre, University of Strathclyde, Glasgow, G1 1RD, UK
(5) Analytical Chemistry Department, Faculty of Pharmacy, Helwan University, Ain Helwan, Cairo, 11795, Egypt
(*) Corresponding Author

Received: 28 May 2019 | Revised: 19 Aug 2019 | Accepted: 24 Aug 2019 | Published: 31 Dec 2019 | Issue Date: December 2019

Abstract


Daclatasvir (DAC), sofosbuvir (SOF) and ribavirin (RIB) have been recently co-formulated in tablet dosage form for the treatment of Hepatitis C virus infections. In this work, the resolution and quantitation of overlapped spectral signals was achieved by both univariate and multivariate algorithms. Pure component contribution algorithm (PCCA) as a novel approach was applied along with factor based partial least squares (PLS) algorithms using both full range and synergistic intervals (siPLS). Each drug could be determined at its λmax using PCCA, while PLS and siPLS were used for multivariate determination of the three components. Good linear relationships were obtained in the ranges of 5.45-16.35, 4.40-44.00 and 5.50-35.00 µg/mL for DAC, SOF and RIB, respectively, by PCCA. The PLS and siPLS models were built for the three compounds each in the concentration range of 2.00-10.00, 10.00-20.00 and 10.00-26.00 µg/mLfor DAC, SOF and RIB, respectively. Validation of the proposed methods was ascertained according to ICH guidelines for PCCA and through the use of internal and external validation sets for PLS and SiPLS models. The three methods were successfully applied for determination of DAC, SOF and RIB in pure form and in tablets.


Keywords


PLS; PCCA; siPLS; Ribavirin; Sofosbuvir; Daclatasvir

Full Text:

PDF /    /


DOI: 10.5155/eurjchem.10.4.350-357.1899

Links for Article


| | | | |

| | | | | | |

Related Articles




Article Metrics

This Abstract was viewed 73 times | PDF Article downloaded 23 times


References

[1]. Alter, M. J. World J. Gastroentero. 2007, 13(17), 2436-2441.
https://doi.org/10.3748/wjg.v13.i17.2436

[2]. Pelosi, L. A.; Voss, S.; Liu, M.; Gao, M.; Lemm, J. A. Antimicrob. Agents Ch. 2012, 56(10), 5230-5239.
https://doi.org/10.1128/AAC.01209-12

[3]. Alavian, S. M.; Rezaee-Zavareh, M. S. Hepat. Mon. 2016, 16(9), e41077, 1-15.
https://doi.org/10.5812/hepatmon.41077

[4]. Guedj, J.; Dahari, H.; Rong, L.; Sansone, N. D.; Nettles, R. E.; Cotler, S. J.; Layden, T. J.; Uprichard, S. L.; Perelson, A. S. Proc. Natl. Acad. Sci. USA 2013, 110(10), 3991-3996.
https://doi.org/10.1073/pnas.1203110110

[5]. Sultan, M. A.; El-Alamin, M. M. A.; Wark, A. W.; Azab, M. M. Spectrochim. Acta, A 2019, 211, 52-58.
https://doi.org/10.1016/j.saa.2018.11.023

[6]. Sulkowski, M. S.; Gardiner, D. F.; Rodriguez-Torres, M.; Reddy, K. R.; Hassanein, T.; Jacobson, I.; Lawitz, E.; Lok, A. S.; Hinestrosa, F.; Thuluvath, P. J. New Engl. J. Med. 2014, 370(3), 211-221.
https://doi.org/10.1056/NEJMoa1306218

[7]. Sweetman, S. C.; Blake, P., Martindale, 37th edition. Pharmaceutical Press, 2011.

[8]. Fontaine, H.; Hezode, C.; Zoulim, F.; Samuel, D.; Bourliere, M.; Haour, G.; Dorival-Mouly, C.; Leroy, V.; De Ledinghen, V.; Lucier, S. The international Liver Congress™ 2015-50th Annual meeting of the European Association for the Study of the Liver, 2015, p. S278.
https://doi.org/10.1016/S0168-8278(15)30182-3

[9]. Pol, S.; Corouge, M.; Vallet-Pichard, A. Hepat Med. 2016, 8, 21-26.
https://doi.org/10.2147/HMER.S62014

[10]. Magdy, A. W.; Samia, M. M.; Sobhy, M. E. A.; Mohamed, S. E. J. Pharm. Biol. Sci. 2017, 12 (5), 60-68.

[11]. Hassan, W. S.; Elmasry, M. S.; Elsayed, H. M.; Zidan, D. W. Spectrochim. Acta A 2018, 202, 159-173.
https://doi.org/10.1016/j.saa.2018.05.041

[12]. B.M. Wise, N. B. G., Version 2.1.1 Ed. Eigenvector Research, Inc.,. 2001.

[13]. MATLAB 6.5, The MathWorks, Inc., Natick, Massachusetts, United States.

[14]. Brereton, R. G. Analyst 1997, 122(12), 1521-1529.
https://doi.org/10.1039/a703654j

[15]. Hegazy, M. A. M. Spectrochim. Acta A 2015, 151, 405-414.
https://doi.org/10.1016/j.saa.2015.06.102

[16]. Toubar, S. S.; Hegazy, M. A.; Elshahed, M. S.; Helmy, M. I. Spectrochim. Acta A 2016, 163, 89-95.
https://doi.org/10.1016/j.saa.2016.03.035

[17]. Haaland, D. M.; Thomas, E. V. Anal. Chem. 1988, 60(11), 1193-1202.
https://doi.org/10.1021/ac00162a020

[18]. Hegazy, M. A.; Boltia, S. A.; Fayed, A. S.; Musaed, A. Spectrochim. Acta A 2018, 202, 359-367.
https://doi.org/10.1016/j.saa.2018.05.038

[19]. Parisotto, G.; Ferrao, M. F.; Müller, A. L.; Müller, E. I.; Santos, M. F.; Guimaraes, R. C.; Dias, J. C.; Flores, E. M. Energ Fuel 2010, 24(10), 5474-5478.
https://doi.org/10.1021/ef1002974

[20]. Shah, D.; He, Q. P.; Wang, J. IFAC PapersOnLine 2018, 51(18), 369-374.
https://doi.org/10.1016/j.ifacol.2018.09.328

[21]. Guideline, I. H. T. International Conference on Harmonization, Geneva, Switzerland, 2005; pp. 11-12.

[22]. Elfatatry, H. M.; Mabrouk, M. M.; Hammad, S. F.; Mansour, F. R.; Kamal, A. H.; Alahmad, S. J. AOAC Int. 2016, 99(5), 1247-1251.
https://doi.org/10.5740/jaoacint.16-0106

[23]. Hemmateenejad, B.; Akhond, M.; Samari, F. Spectrochim. Acta A 2007, 67(3-4), 958-965.
https://doi.org/10.1016/j.saa.2006.09.014

[24]. El-Gindy, A.; Emara, S.; Shaaban, H. J. Pharmaceut. Biomed. 2007, 43(3), 973-982.
https://doi.org/10.1016/j.jpba.2006.09.020

[25]. Hadad, G. M.; El-Gindy, A.; Mahmoud, W. M. Spectrochim. Acta A 2008, 70(3), 655-663.
https://doi.org/10.1016/j.saa.2007.08.016

[26]. Martens, H.; Naes, T., Multivariate calibration: A user-friendly guide to multivariate calibration and classification. John Wiley & Sons, New York: 1989.

[27]. Espinosa-Mansilla, A.; Duran-Meras, I.; Salinas, F. J. Pharmaceut. Biomed. 1998, 17(8), 1325-1334.
https://doi.org/10.1016/S0731-7085(98)00036-3

[28]. Wagieh, N. E.; Hegazy, M. A.; Abdelkawy, M.; Abdelaleem, E. A. Talanta 2010, 80(5), 2007-2015.
https://doi.org/10.1016/j.talanta.2009.11.002

[29]. Miller, J.; Miller, J. C., Statistics and chemometrics for analytical chemistry. Pearson Education, Canada, 2005.

How to cite


El-Alamin, M.; Sultan, M.; Hegazy, M.; Wark, A.; Azab, M. Eur. J. Chem. 2019, 10(4), 350-357. doi:10.5155/eurjchem.10.4.350-357.1899
El-Alamin, M.; Sultan, M.; Hegazy, M.; Wark, A.; Azab, M. Pure component contribution (PCCA) and synergy interval partial least squares (siPLS) algorithms for efficient resolution and quantification of overlapped signals; an application to novel antiviral tablets of daclatasvir, sofosbuvir and ribavirin. Eur. J. Chem. 2019, 10(4), 350-357. doi:10.5155/eurjchem.10.4.350-357.1899
El-Alamin, M., Sultan, M., Hegazy, M., Wark, A., & Azab, M. (2019). Pure component contribution (PCCA) and synergy interval partial least squares (siPLS) algorithms for efficient resolution and quantification of overlapped signals; an application to novel antiviral tablets of daclatasvir, sofosbuvir and ribavirin. European Journal of Chemistry, 10(4), 350-357. doi:10.5155/eurjchem.10.4.350-357.1899
El-Alamin, Maha, Maha Abd Elrahman Sultan, Maha Hegazy, Alastair William Wark, & Marwa Mohamed Azab. "Pure component contribution (PCCA) and synergy interval partial least squares (siPLS) algorithms for efficient resolution and quantification of overlapped signals; an application to novel antiviral tablets of daclatasvir, sofosbuvir and ribavirin." European Journal of Chemistry [Online], 10.4 (2019): 350-357. Web. 20 Jan. 2020
El-Alamin, Maha, Sultan, Maha, Hegazy, Maha, Wark, Alastair, AND Azab, Marwa. "Pure component contribution (PCCA) and synergy interval partial least squares (siPLS) algorithms for efficient resolution and quantification of overlapped signals; an application to novel antiviral tablets of daclatasvir, sofosbuvir and ribavirin" European Journal of Chemistry [Online], Volume 10 Number 4 (31 December 2019)

DOI Link: https://doi.org/10.5155/eurjchem.10.4.350-357.1899

| | | | |

| | | | | |

Save to Zotero Save to Mendeley

European Journal of Chemistry 2019, 10(4), 350-357 | doi: https://doi.org/10.5155/eurjchem.10.4.350-357.1899 | Get rights and content

Refbacks

  • There are currently no refbacks.




Copyright (c) 2019 Authors

Creative Commons License
This work is published and licensed by Atlanta Publishing House LLC, Atlanta, GA, USA. The full terms of this license are available at http://www.eurjchem.com/index.php/eurjchem/pages/view/terms and incorporate the Creative Commons Attribution-Non Commercial (CC BY NC) (International, v4.0) License (http://creativecommons.org/licenses/by-nc/4.0). By accessing the work, you hereby accept the Terms. This is an open access article distributed under the terms and conditions of the CC BY NC License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited without any further permission from Atlanta Publishing House LLC (European Journal of Chemistry). No use, distribution or reproduction is permitted which does not comply with these terms. Permissions for commercial use of this work beyond the scope of the License (http://www.eurjchem.com/index.php/eurjchem/pages/view/terms) are administered by Atlanta Publishing House LLC (European Journal of Chemistry).


© Copyright 2019  Atlanta Publishing House LLC All Right Reserved.

The opinions expressed in all articles published in European Journal of Chemistry are those of the specific author(s), and do not necessarily reflect the views of Atlanta Publishing House LLC, or European Journal of Chemistry, or any of its employees.

Copyright 2019 Atlanta Publishing House LLC. All rights reserved. This site is owned and operated by Atlanta Publishing House LLC whose registered office is 4614 Lavista road, Tucker, GA, 30084, USA. Registered in USA.